Welcome Guest!  Login | Register | Help | Survey
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
AMRI [NASD]
Albany Molecular Research Inc.
Services - Research Services - USA
Index- P/E46.83 EPS (ttm)0.18 Insider Own33.28% Shs Outstand31.64M Perf Week-11.17%
Market Cap266.73M Forward P/E49.59 EPS next Y0.17 Insider Trans-0.04% Shs Float21.11M Perf Month-8.67%
Income5.63M PEG4.68 EPS next Q-0.07 Inst Own64.80% Short Float4.31% Perf Quarter0.60%
Sales209.39M P/S1.27 EPS this Y137.46% Inst Trans-0.73% Short Ratio11.79 Perf Half Y-4.20%
Book/sh10.52 P/B0.80 EPS next Y466.67% ROA1.42% Target Price8.00 Perf Year-12.55%
Cash/sh3.26 P/C2.59 EPS next 5Y10.00% ROE1.69% 52W Range7.31 - 12.56 Perf YTD-7.16%
Dividend- P/FCF17.57 EPS past 5Y-7.37% ROI1.55% 52W High-32.64% Beta1.18
Dividend %- Quick Ratio4.87 Sales past 5Y3.15% Gross Margin29.19% 52W Low15.73% ATR0.39
Employees1357 Current Ratio5.57 Sales Q/Q-22.32% Oper. Margin3.24% RSI (14)35.12 Volatility4.41% 4.19%
OptionableYes Debt/Eq0.04 EPS Q/Q-94.73% Profit Margin2.69% Rel Volume2.70 Prev Close8.43
ShortableYes LT Debt/Eq0.04 EarningsFeb 08 BMO Payout0.00% Avg Volume77.17K Price8.46
Recom3.00 SMA20-8.32% SMA50-6.28% SMA200-3.86% Volume208,208 Change0.36%
14-Jul-09Upgrade Jefferies & Co Underperform → Hold $8
10-Feb-09Reiterated Jefferies & Co Underperform $8 → $9
05-Dec-08Downgrade Jefferies & Co Hold → Underperform $10 → $8
17-Jul-08Downgrade Jefferies & Co Buy → Hold $15.50
20-Jun-07Initiated Susquehanna Financial Neutral
07-May-07Upgrade Jefferies & Co Hold → Buy $11.50 → $14.50
08-Feb-10 10:05AM  AMRI reports $19M net loss in 4Q at bizjournals.com
08:22AM  ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
07:00AM  AMRI Announces Fourth Quarter 2009 Results Business Wire
02-Feb-10 08:00AM  AMRI CFO to Present at UBS 20th Annual Global Healthcare Services Conference Business Wire
01-Feb-10 08:00AM  AMRI to Announce Fourth Quarter Results Business Wire
27-Jan-10 02:12PM  Research And Development Expenditures In Diagnostic And Lab Equipment Sector Raises Capital Requirements: Will Acquisitions By Larger Health Care Companies Be The Result? Wall Street Transcript
19-Jan-10 12:49PM  AMRI CFO to Present at Jefferies 2010 Global Healthcare Services Conference Business Wire
08:00AM  AMRI Receives SafeBridge Potent Compound Safety Certification Business Wire
07-Jan-10 08:01AM  AMRI CEO to Present at 28th Annual J.P. Morgan Healthcare Conference Business Wire +5.49%
09-Dec-09 10:05PM  Bruno name stays put in Capital Region at bizjournals.com
13-Nov-09 09:05AM  ALBANY MOLECULAR RESEARCH INC Financials EDGAR Online Financials
09-Nov-09 10:05AM  AMRIs quarterly earnings, revenue down at bizjournals.com
08:00AM  ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
07:07AM  Q3 2009 Albany Molecular Research Earnings Release - Before Market Open CCBN
07:00AM  AMRI Announces Third Quarter 2009 Results Business Wire
02-Nov-09 12:05PM  AMRI receives $750K milestone payment at bizjournals.com
08:01AM  InPlay: Albany Molecular announces that a third compound being developed under its license and research agreement with Bristol-Myers Squibb Briefing.com
08:00AM  Third Compound from AMRI Bristol-Myers Squibb Collaboration Selected for Preclinical Development Business Wire
30-Oct-09 09:25AM  AMRI to Present at the Oppenheimer 20th Annual Healthcare Conference Business Wire
26-Oct-09 10:00AM  AMRI to Announce Third Quarter Results Business Wire
22-Oct-09 03:05PM  Daines: Treat flu-like symptoms as H1N1 at bizjournals.com
20-Oct-09 03:05PM  Panel to focus on H1N1s impact on business community at bizjournals.com
22-Sep-09 03:24PM  Governor Christine Gregoire Officially Dedicates New AMRI Research Facility in Bothell, Washington Business Wire
17-Sep-09 11:05AM  CFO of the Year finalists named at bizjournals.com
16-Sep-09 08:00AM  AMRI CFO to Present at UBS 2009 Global Life Sciences Conference Business Wire
15-Sep-09 10:56AM  Albany Molecular files Allegra patent lawsuits AP
10:05AM  AMRI files 2 patent-infringement lawsuits at bizjournals.com
08:00AM  AMRI Files New Patent Infringement Lawsuits against Dr. Reddy's Laboratories and Sandoz Business Wire
06-Aug-09 11:52AM  ALBANY MOLECULAR RESEARCH INC Files SEC form 10-Q, Quarterly Report EDGAR Online
05-Aug-09 03:25PM  Bowne & Co, Albany Molecular Research and Dolan Media lead small-cap percentage losers SmallCapInvestor.com -13.11%
11:05AM  Albany Molecular reports 2nd-Q profit drop at bizjournals.com
06:02AM  ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
04-Aug-09 06:00PM  AMRI Announces Second Quarter 2009 Results Business Wire
07:07AM  Q2 2009 Albany Molecular Research Earnings Release - After Market Close CCBN
29-Jul-09 08:00AM  AMRI to Announce Second Quarter Results Business Wire
14-Jul-09 04:47AM  Albany Molecular upgraded by Jefferies & Co Briefing.com +7.16%
06-Jul-09 12:05PM  Evident Technologies files Chapter 11 bankruptcy petition at bizjournals.com
01-Jul-09 02:05PM  Companies plan for layoffs as Power for Jobs program expires at bizjournals.com
22-Jun-09 10:05AM  AMRI finishes building Budapest plant at bizjournals.com
08:00AM  AMRI Opens New Research Facility in Budapest, Hungary Business Wire
15-Jun-09 08:00AM  AMRI Announces Changes in India Operations Business Wire
10-Jun-09 08:00AM  AMRI to Present at Jefferies 3rd Annual Healthcare Conference Business Wire
02-Jun-09 08:00AM  AMRI Advances New Obesity Treatment Toward IND Submission Business Wire
26-May-09 08:00AM  Phase I Testing to Commence on Second Compound Developed from AMRI, Bristol-Myers Squibb Collaboration Business Wire +6.90%
12-May-09 12:23PM  AMRI CFO to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference Business Wire
07-May-09 02:51PM  Movers roundup: Urban Outfitters, Hot Topic AP -6.82%
11:04AM  Albany Molecular shares fall on 1Q profit, outlook AP
06:02AM  ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
06-May-09 06:00PM  AMRI Announces First Quarter 2009 Results Business Wire
08:00AM  AMRI to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference Business Wire
07:07AM  Q1 2009 Albany Molecular Research Earnings Release - After Market Close CCBN
29-Apr-09 10:05AM  AMRI collaborating with CHDI Foundation at bizjournals.com
08:00AM  AMRI Commences Drug Discovery Collaboration with CHDI Business Wire
23-Apr-09 08:00AM  AMRI to Announce First Quarter Results Business Wire
21-Apr-09 01:33PM  Research Contractors Slammed After Kendle Warns Investors Indie Research
20-Apr-09 09:00AM  AMRI Relocates Bothell R&D Facility Business Wire -5.33%
22-Mar-09 05:54AM  19 'Bathwater Babies' and 20 'Dogs with Fleas' Stocks for the Week at Seeking Alpha
13-Mar-09 01:56PM  ALBANY MOLECULAR RESEARCH INC Files SEC form 10-K, Annual Report EDGAR Online +6.30%
04-Mar-09 04:41PM  ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online +9.66%
07:05AM  AMRI expands CFO's role at bizjournals.com
03-Mar-09 09:31AM  AMRI Announces Promotion for CFO Mark T. Frost Business Wire
10-Feb-09 09:25AM  New Star Analyst Rankings for Albany Molecular Research, Inc. StarMine
09-Feb-09 04:58PM  Small caps close lower; HBAN, FITB and MLR lead gainers SmallCapInvestor.com +9.85%
03:09PM  Russell turns red into mid-session; HBAN, AMRI, and FITB lead gainers SmallCapInvestor.com
02:32PM  For Antidepressants, Maybe Three Targets Will Be Better than Two at The Wall Street Journal Online
10:52AM  Week starts out low for small-cap stocks; HBAN, AMRI, and VOLC lead gainers SmallCapInvestor.com
10:05AM  AMRI net income up 130% in 08 at bizjournals.com
07:07AM  Q4 2008 Albany Molecular Research Earnings Release - Before Market Open CCBN
07:00AM  AMRI Announces Fourth Quarter 2008 Results Business Wire
05-Feb-09 11:16AM  AMRI to Present at UBS 2009 Global Healthcare Services Conference Business Wire
03-Feb-09 08:48AM  ADDING MULTIMEDIA AMRI Appoints New General Manager of Large Scale Manufacturing Business Wire
02-Feb-09 08:00AM  AMRI to Announce Fourth Quarter Results Business Wire
26-Jan-09 08:00AM  AMRI Appoints Director of Global Project Management Business Wire
14-Jan-09 05:35PM  In Pictures: Buying Diamonds, Selling Stationery at Forbes.com
12-Jan-09 04:05PM  ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
09:11AM  AMRI Names Senior Director, Analytical and Quality Services Business Wire
08-Jan-09 02:43PM  5 Stocks Ready for Liftoff at Motley Fool
09:00AM  AMRI to Present at 27th Annual J.P. Morgan Healthcare Conference Business Wire
22-Dec-08 12:05PM  New upstate board created by Fed Reserve Bank at bizjournals.com
09-Dec-08 01:00AM  Using Short Ratio at Market Bottom Zacks.com
08-Dec-08 08:08AM  Analyst Actions: Safeway, Berry Petroluem, Albany Molecular Research at BusinessWeek
05-Dec-08 06:44PM  Movers roundup: Boeing, Smithfield Foods AP -5.17%
03:33PM  Albany Molecular shares fall on Jefferies outlook AP
10:57AM  UPDATE - Jefferies downgrades Albany Molecular, shares down at Reuters
01-Dec-08 12:05PM  Achievement Awards - Clint Ballinger at bizjournals.com -8.54%
19-Nov-08 10:05AM  AMRI settles patent dispute with rivals at bizjournals.com
09:27AM  Israel Stocks: Market lower; Teva settles patent case, wins a round in another at MarketWatch
08:32AM  ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosur EDGAR Online
07:26AM  Teva, Barr settle patent dispute with Sanofi AP
02:50AM  Teva, Barr, Sanofi, Albany Molecular settle patent disputes at MarketWatch
01:30AM  AMRI Announces Agreement with Teva Pharmaceuticals and Barr Laboratories to Settle Litigation in ALLEGRA and ALLEGRAD-12 U.S. Patent Dispute Business Wire
18-Nov-08 07:37AM  Albany Molecular Research, Inc. Q3 2008 Earnings Call Transcript at Seeking Alpha
07-Nov-08 04:55PM  ALBANY MOLECULAR RESEARCH INC Files SEC form 10-Q, Quarterly Report EDGAR Online
06-Nov-08 10:05AM  AMRIs net income jumps 250% in 3Q at bizjournals.com
05-Nov-08 05:21PM  ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online -8.83%
05:00PM  AMRI Announces Third Quarter 2008 Results Business Wire
07:07AM  Q3 2008 Albany Molecular Research Earnings Release - After Market Close CCBN
03-Nov-08 08:55AM  CEG names new board members at bizjournals.com +5.93%
30-Oct-08 09:25AM  AMRI Presents Preclinical Data for Tubulin Inhibitor, ALB109564(a), at EORTC-NCI-AACR Symposium Business Wire
08:00AM  AMRI to Announce Third Quarter Results Business Wire
Albany Molecular Research, Inc. provides contract services to various pharmaceutical and biotechnology companies primarily in the United States and Europe. The company offers drug discovery services, including assay development and design; screening programs, which provide tools to identify active compounds during the lead discovery phases of drug discovery; libraries for screening and hit-to-lead programs; bioanalytical services for extraction and quantitation of drug and metabolites in biological fluids and tissues; and natural product services. Its drug discovery services also include lead optimization, a process of altering the chemical structure of a confirmed hit to identify an improved drug lead; medicinal chemistry to modify the structure of a hit compound to synthesize new molecules; computer-aided drug discovery services to identify novel hits or leads against selected therapeutic targets, as well as to support medicinal chemistry lead optimization programs; in vitro ADMET assays to evaluate and improve metabolism, bioavailability, pharmacology, and toxicology of compounds; and preparative chromatography, a separation service. The company's chemical development services include process research and development; custom synthesis; process safety assessment; high potency and controlled substances; building blocks database; IND support services; fermentation development and optimization; and chemical synthesis and manufacturing services. Its analytical services include impurity identification and structure elucidation; method development, qualification, and validation; preformulation and physical characterization; quality control; regulatory support; and stability services. The company also serves agricultural and fine chemical companies, contract chemical manufacturers, government research entities, and non-profit organizations. Albany Molecular Research was founded in 1991 and is based in Albany, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hagen Steven RVP Pharmaceutical Dev & MfgNov 19Sale8.051,50012,07519,989Nov 20 10:45 AM
Hagen Steven RVP Pharmaceutical Dev & MfgNov 16Sale8.472,00016,94021,489Nov 16 01:51 PM
Hagen Steven RVP Pharmaceutical Dev & MfgAug 06Sale8.799007,91123,489Aug 06 04:13 PM
Hagen Steven RVP Pharmaceutical Dev & MfgFeb 12Sale10.492,00020,98020,889Feb 12 11:12 AM